
SEC exempt reporting adviser
Banyan Bio
Banyan BioInnovations is an investment firm backed by Locust Walk that builds and runs asset-focused new companies around clinical-stage drug candidates, sourcing across the U.S., China and Japan.
Investment activity
Round-by-round activity is part of PRO
Key signal this week
Is Banyan Bio right for your round?
Key stats
Fund cycle Public record
Fund vehicles on public registers (SEC adviser filings). Values are the gross assets each filing reports, not fund sizes.
Latest investments
Rounds Banyan Bio joined, from press and the firm’s own posts.
Every round Banyan Bio joined
Round sizes, Banyan Bio’s role and who invested alongside.
Where the money goes
Share of companies at first investment, from the rounds we track.
Investment team
Where to meet Banyan Bio
Events where Banyan Bio’s team spoke or showed up, from event programmes, press and the firm’s own posts.
Signals
Register and fund filings are free. Website, team and portfolio changes we pick up are PRO.
Founders also look at
Frequently asked questions
Banyan Bio is based in Boston, United States.
1 fund vehicle is on public registers (SEC adviser filings), including BANYAN BIOINNOVATIONS CAPITAL FUND I LP.
Sectors: Life sciences. From the firm’s own website.
Creates single-asset companies around clinical-stage drugs with clear regulatory paths and best- or first-in-class potential. A centralized, experienced development team runs clinical and regulatory work while originators keep upside, aiming for defined value inflection points with disciplined capital. From the firm’s own website.
Know before Banyan Bio’s next round is announced.
PRO tracks Banyan Bio’s filings, hires and portfolio changes the day they land, alongside 3,869 other firms.